MASTER CLINICAL TRIAL AGREEMENT(“Agreement”) entered into as of 20 October 2016 (the "Effective Date") by and between Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11, 1121 Vienna, AustriaVAT-ID-No.: ATU 64226215("Sponsor”) andGeneral...Master Clinical Trial Agreement • November 7th, 2020
Contract Type FiledNovember 7th, 2020RECITALS WHEREAS, Sponsor, a research-driven pharmaceutical company, is sponsoring and conducting a clinical trials of various compounds (“Investigational Product”) according to a specific Clinical Trial Protocol for each clinical trial (“Protocol”); and WHEREAS, Institution may, subject to written agreement, participate as an investigative site in one or more clinical trials (hereinafter referred to as “Trial” and collectively the “Trials”); and WHEREAS, Sponsor may engage a Contract Research Organisation (“CRO”), to act as an independent contractor, but not as a party to this Agreement, to carry out on behalf of Sponsor certain of Sponsor’s responsibilities with respect to the Trial, which may include, but are not limited to, contract negotiation and management, site payment, site monitoring, and/or other Trial related activities; and WHEREAS, Sponsor seeks to engage the services of Institution to carry out a Trial in accordance with the Protocol; and WHEREAS, Institution operates a